Cy3 Goat Anti-Human IgG (H+L) Antibody: Mechanism, Evidence, and Workflow Integration

Executive Summary: The Cy3 Goat Anti-Human IgG (H+L) Antibody is a polyclonal secondary antibody, affinity-purified and labeled with Cy3, targeting human IgG with high specificity and minimal cross-reactivity (product_spec). It is validated for use in immunocytochemistry, immunohistochemistry, flow cytometry, and ELISA, enabling robust signal amplification through multivalent binding (workflow_recommendation). The Cy3 fluorophore on this antibody emits at 565 nm, facilitating sensitive fluorescence-based detection (product_spec). Proper storage and handling (aliquoting, protection from light, -20°C) are essential for preserving reagent performance (product_spec). Benchmarking studies confirm its reproducibility and low background across multiple sample types (workflow_recommendation).

Biological Rationale

Secondary antibody systems are foundational for the detection of primary antibodies and their bound antigens in immunoassays. The Cy3 Goat Anti-Human IgG (H+L) Antibody is designed to recognize both heavy and light chains of human IgG, maximizing detection of diverse IgG subclasses. Its affinity purification reduces non-specific interactions, which is critical for high-precision applications such as immunofluorescence assay and flow cytometry antibody protocols (product_spec).

Mechanism of Action of Cy3 Goat Anti-Human IgG (H+L) Antibody

This antibody is generated by immunizing goats with pooled human immunoglobulins, followed by immunoaffinity chromatography purification. It is conjugated with Cy3, a fluorophore that absorbs maximally at 552 nm and emits at 565 nm, supporting sensitive detection in standard fluorescence microscopy setups (product_spec). The antibody binds to human IgG (heavy and light chain epitopes), enabling the visualization of target proteins or cells labeled by human IgG primary antibodies. Its polyclonal nature allows binding to multiple epitopes, increasing signal amplification and detection sensitivity (workflow_recommendation).

Evidence & Benchmarks

• The Cy3 Goat Anti-Human IgG (H+L) Antibody demonstrates high specificity for human IgG with minimal cross-reactivity to other species (product_spec).
• In immunofluorescence assays, Cy3 conjugation enables detection limits down to low nanomolar concentrations of human IgG (workflow_recommendation).
• Validated for use in immunocytochemistry (ICC/IF), frozen and paraffin-embedded immunohistochemistry (IHC-Fr, IHC-P), flow cytometry, and ELISA platforms (workflow_recommendation).
• Storage at -20°C with 23% glycerol preserves antibody performance for up to 12 months (source: product_spec).
• Affinity purification ensures low background and improved reproducibility in quantitative immunoassays (workflow_recommendation).
• Signal amplification is achieved by multiple binding events of secondary antibody to each primary antibody, increasing fluorescence intensity (workflow_recommendation).
• Benchmarked in translational and clinical assay workflows for robust detection of human antibodies, including in orthopoxvirus studies where antibody characterization is critical (paper).

For a detailed discussion of workflow challenges and enhancements, see "Enhancing Immunoassay Reliability: Cy3 Goat Anti-Human Ig...", which this article extends by cataloging specific mechanistic and quantitative evidence.

Applications, Limits & Misconceptions

The Cy3 Goat Anti-Human IgG (H+L) Antibody is suitable for secondary detection in immunofluorescence, immunohistochemistry, flow cytometry, and ELISA (product_spec). Its robust performance has been leveraged in antibody characterization, including in orthopoxvirus research to validate antibody binding and specificity (paper).

Common Pitfalls or Misconceptions

• It is not suitable for direct detection of non-human immunoglobulins; cross-reactivity is minimized but not eliminated (source: product_spec).
• Repeated freeze-thaw cycles can degrade both antibody and Cy3 fluorophore, reducing performance (source: product_spec).
• Exposure to strong light will quench Cy3 fluorescence; always protect from light during storage and handling (source: workflow_recommendation).
• Not validated for in vivo imaging or therapeutic use; designed for in vitro research only (source: workflow_recommendation).
• Signal amplification is dependent on primary antibody accessibility; epitope masking or low primary antibody concentration will limit detection (source: workflow_recommendation).

For further insight into the antibody's impact on translational assay precision, see "Cy3 Goat Anti-Human IgG (H+L) Antibody: Scientific Precision & New Frontiers", which this article updates with detailed storage and workflow integration guidance.

Workflow Integration & Parameters

Optimal results require adherence to precise protocol parameters and best practices:

Protocol Parameters

• immunofluorescence (ICC/IF) | 1–10 μg/mL | validated for cell and tissue imaging | ensures high signal-to-noise with minimal background | product_spec
• immunohistochemistry (IHC-Fr/IHC-P) | 1–5 μg/mL | compatible with both frozen and paraffin-embedded sections | balances penetration and specificity | product_spec
• flow cytometry | 0.1–1 μg/10⁶ cells | enables quantification of IgG-bound cell populations | prevents fluorophore saturation and minimizes spillover | workflow_recommendation
• ELISA | 0.05–0.5 μg/mL | secondary detection in sandwich or indirect formats | maximizes sensitivity while avoiding non-specific signal | product_spec
• storage | -20°C, protected from light | all applications | preserves antibody and fluorophore integrity up to 12 months | product_spec
• avoid repeated freeze-thaw | single-use aliquots | all applications | prevents Cy3 and antibody degradation | workflow_recommendation

For advanced integration strategies, "Cy3 Goat Anti-Human IgG: Precision in Translational Immunoassays" provides translational workflow perspectives; this article adds detailed protocol parameterization and highlights APExBIO's manufacturing controls.

Conclusion & Outlook

The Cy3 Goat Anti-Human IgG (H+L) Antibody from APExBIO is a validated, high-performance secondary antibody for sensitive detection of human IgG in multiple immunoassay formats. Its robust affinity purification and Cy3 labeling support precise, reproducible results, as confirmed in both peer-reviewed orthopoxvirus antibody characterization studies and controlled workflow analyses (paper). Ongoing improvements in antibody production and conjugation chemistry continue to enhance assay reliability. This reagent remains a critical component for bridging fundamental immunology and translational research workflows, particularly where specificity and signal amplification are required. Future advances will likely focus on multiplexing capabilities and further reduction of background, as informed by current evidence (workflow_recommendation).